{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:58:29Z","timestamp":1793854709995,"version":"4.6.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["FAMP202110K"],"award-info":[{"award-number":["FAMP202110K"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["21NSFCP27"],"award-info":[{"award-number":["21NSFCP27"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260458"],"award-info":[{"award-number":["82260458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118566","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T22:52:19Z","timestamp":1759791139000},"page":"118566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Membrane-coated BLM gene silencing plasmids and doxorubicin nanoparticles targeted for synergistic inhibition of triple-negative breast cancer"],"prefix":"10.1016","volume":"192","author":[{"given":"Haifeng","family":"Ai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1982-2587","authenticated-orcid":false,"given":"Jielin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118566_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA a cancer journal clinicians"},{"issue":"24","key":"10.1016\/j.biopha.2025.118566_bib2","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the st gallen international expert consensus on the primary therapy of early breast cancer","volume":"2013","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.biopha.2025.118566_bib3","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/med.22058","article-title":"Poly (adenosine diphosphate-ribose) polymerase inhibitors in the treatment of triple-negative breast cancer with homologous repair deficiency","volume":"44","author":"Yuan","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2025.118566_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jphotobiol.2016.02.032","article-title":"Review on the binding of anticancer drug doxorubicin with DNA and trna: structural models and antitumor activity","volume":"158","author":"Agudelo","year":"2016","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.biopha.2025.118566_bib5","article-title":"Mechanistic insights into carvedilol's potential protection against doxorubicin-induced cardiotoxicity","volume":"200","author":"Elmorsy","year":"2024","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118566_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161941","article-title":"Small molecules that disrupt rad54-blm interaction hamper tumor proliferation in colon cancer chemoresistance models","volume":"134","author":"Kaur","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2025.118566_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00294-021-01190-3","article-title":"A deep dive into the recq interactome: something old and something new","volume":"67","author":"Simmons","year":"2021","journal-title":"Curr. Genet."},{"key":"10.1016\/j.biopha.2025.118566_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tibs.2008.09.003","article-title":"Rising from the recq-age: the role of human recq helicases in genome maintenance","volume":"33","author":"Bohr","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2025.118566_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4614-5037-5_8","article-title":"Recq helicases: conserved guardians of genomic integrity","volume":"767","author":"Larsen","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2025.118566_bib10","first-page":"1347","article-title":"Blm interaction with ezh2 regulates mdm2 expression and is a poor prognostic biomarker for prostate cancer","volume":"11","author":"Ruan","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.biopha.2025.118566_bib11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1158\/1535-7163.MCT-14-0939","article-title":"Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (blm) in breast cancer","volume":"14","author":"Arora","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118566_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/srep14060","article-title":"Deleterious germline blm mutations and the risk for early-onset colorectal cancer","volume":"5","author":"de Voer","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118566_bib13","article-title":"Bisbenzylisoquinoline alkaloid fangchinoline derivative hy-2 inhibits breast cancer cells by suppressing blm DNA helicase","volume":"169","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118566_bib14","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.3892\/ol.2017.6704","article-title":"Recq helicase blm regulates prostate cancer cell proliferation and apoptosis","volume":"14","author":"Qian","year":"2017","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2025.118566_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3892\/mmr.2022.12829","article-title":"Downregulation of blm recq helicase inhibits proliferation, promotes the apoptosis and enhances the sensitivity of bladder cancer cells to cisplatin","volume":"26","author":"Feng","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.118566_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11033-025-10247-2","article-title":"Blm knockdown promotes cells autophagy via p53-ampk-mtor pathway in triple negative breast cancer cells","volume":"52","author":"Wang","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2025.118566_bib17","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.20892\/j.issn.2095-3941.2021.0178","article-title":"Blm helicase inhibition synergizes with parp inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair","volume":"19","author":"Kong","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"24","key":"10.1016\/j.biopha.2025.118566_bib18","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.3390\/molecules27248790","article-title":"Ml216-induced blm helicase inhibition sensitizes pca cells to the DNA-crosslinking agent cisplatin","volume":"27","author":"Ma","year":"2022","journal-title":"Mol. (Basel Switz. )"},{"key":"10.1016\/j.biopha.2025.118566_bib19","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1158\/0008-5472.CAN-10-0475","article-title":"The human wrn and blm recq helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage","volume":"70","author":"Mao","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118566_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.983181","article-title":"The blm helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance","volume":"13","author":"Ovejero","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118566_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.addr.2014.09.010","article-title":"Combination of microrna therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers","volume":"81","author":"Dai","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118566_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40824-016-0081-3","article-title":"Lipid-based surface engineering of plga nanoparticles for drug and gene delivery applications","volume":"20","author":"Bose","year":"2016","journal-title":"Biomater. Res."},{"key":"10.1016\/j.biopha.2025.118566_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101536","article-title":"Plga's plight and the role of stealth surface modification strategies in its use for intravenous particulate drug delivery","volume":"11","author":"Sheffey","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2025.118566_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"Stealth' corona-core nanoparticles surface modified by polyethylene glycol (peg): influences of the corona (peg chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118566_bib25","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.drudis.2014.08.015","article-title":"Potential induction of anti-peg antibodies and complement activation toward pegylated therapeutics","volume":"19","author":"Verhoef","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118566_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of pegylated plga nanoparticles following repeated injections: effects of polymer dose, peg coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118566_bib27","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.apsb.2021.01.020","article-title":"Cell membrane-derived vesicles for delivery of therapeutic agents","volume":"11","author":"Le","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118566_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.apsb.2017.12.001","article-title":"Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy","volume":"8","author":"Huang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2025.118566_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/cancers13010077","article-title":"Immunocyte membrane-coated nanoparticles for cancer immunotherapy","volume":"13","author":"Gong","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118566_bib30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1080\/17425247.2021.1922387","article-title":"Unleashing the potential of cell membrane-based nanoparticles for covid-19 treatment and vaccination","volume":"18","author":"Pereira-Silva","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118566_bib31","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"key":"10.1016\/j.biopha.2025.118566_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2020.1813109","article-title":"Biomimetic cancer cell membrane-coated nanosystems as next-generation cancer therapies","volume":"17","author":"Pereira-Silva","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118566_bib33","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anticancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"key":"10.1016\/j.biopha.2025.118566_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1270407","article-title":"Research progress of cancer cell membrane coated nanoparticles for the diagnosis and therapy of breast cancer","volume":"13","author":"Zhou","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118566_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1039\/C9BM01392J","article-title":"Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.biopha.2025.118566_bib36","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.1021\/acsnano.6b04695","article-title":"Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy","volume":"10","author":"Chen","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.118566_bib37","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1002\/adma.201602173","article-title":"Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors","volume":"28","author":"Sun","year":"2016","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"key":"10.1016\/j.biopha.2025.118566_bib38","article-title":"Research update on cell membrane camouflaged nanoparticles for cancer therapy","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118566_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"Ualcan: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia (N. Y. NY)"},{"key":"10.1016\/j.biopha.2025.118566_bib40","article-title":"Bc-genexminer 4.5: new mining module computes breast cancer differential gene expression analyses","volume":"2021","author":"J\u00e9z\u00e9quel","year":"2021","journal-title":"Database. J. Biol. Database. Curation"},{"key":"10.1016\/j.biopha.2025.118566_bib41","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gy\u0151rffy","year":"2024","journal-title":"Innov. (Camb. (Mass))"},{"key":"10.1016\/j.biopha.2025.118566_bib42","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10549-011-1457-7","article-title":"Bc-genexminer: an easy-to-use online platform for gene prognostic analyses in breast cancer","volume":"131","author":"J\u00e9z\u00e9quel","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2025.118566_bib43","first-page":"422","article-title":"Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles","volume":"34","author":"Yaman","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2025.118566_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12951-021-01202-x","article-title":"Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer","volume":"19","author":"Chen","year":"2021","journal-title":"J. nanobiotechnology"},{"key":"10.1016\/j.biopha.2025.118566_bib45","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/10717544.2021.1938757","article-title":"Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118566_bib46","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/srep01449","article-title":"A physical sciences network characterization of non-tumorigenic and metastatic cells","volume":"3","author":"Agus","year":"2013","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118566_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12951-025-03161-z","article-title":"Enhanced tumor self-targeting of lemon-derived extracellular vesicles by embedding homotypic cancer cell membranes for efficient drug delivery","volume":"23","author":"Yang","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118566_bib48","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/acs.nanolett.5c01221","article-title":"Nanosized membrane fusion-triggered three-dimensional DNA walker for subtype-specific analysis of breast cancer extracellular vesicles","volume":"25","author":"Fang","year":"2025","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.118566_bib49","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-024-48838-5","article-title":"Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery","volume":"15","author":"Zelepukin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118566_bib50","article-title":"Recent advances in biomimetic cell membrane-camouflaged nanoparticles for cancer therapy","volume":"177","author":"Alimohammadvand","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118566_bib51","first-page":"607","article-title":"Augmented cell death with bloom syndrome helicase deficiency","volume":"4","author":"Kaneko","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2025.118566_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2021.06.013","article-title":"DNA damage and oxidant stress activate p53 through differential upstream signaling pathways","volume":"172","author":"Shi","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.118566_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118566_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103035","article-title":"Dnajc12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of akt","volume":"70","author":"Shen","year":"2024","journal-title":"Redox Biol."},{"issue":"16","key":"10.1016\/j.biopha.2025.118566_bib55","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2217\/nnm-2018-0017","article-title":"The potential of biomimetic nanoparticles for tumor-targeted drug delivery","volume":"13","author":"LI","year":"2018","journal-title":"Nanomed. (Lond. Engl. )"},{"issue":"18","key":"10.1016\/j.biopha.2025.118566_bib56","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1002\/adma.201506086","article-title":"Cancer cell Membrane-Coated upconversion nanoprobes for highly specific tumor imaging","volume":"28","author":"Rao","year":"2016","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"issue":"1","key":"10.1016\/j.biopha.2025.118566_bib57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nnano.2012.212","article-title":"Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions [J]","volume":"8","author":"Parodi","year":"2013","journal-title":"Nat. Nanotechnol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:45:09Z","timestamp":1775781909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"alternative-id":["S0753332225007607"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118566","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Membrane-coated BLM gene silencing plasmids and doxorubicin nanoparticles targeted for synergistic inhibition of triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118566"}}